One of the biggest myths around artificial intelligence is that it can simply create a new medicine on its own. That is not ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced the publication of new data in JAMA Oncology, evaluating the utility of Signatera, its personalized molecular ...

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb), is the world's deadliest single-agent infection, responsible for 1.23 million deaths in 2024, according to the World Health ...

Genomic surveillance—the process of monitoring and sequencing pathogens—is one of the most important tools for detecting ...

Respiratory diseases continue to represent a major global health burden, ranking among the leading causes of morbidity and mortality. They encompass a wide ...

Tole combines ultrasound and AI to improve motor neuron disease diagnosis, reducing reliance on invasive procedures.

Looking ahead to 2030, our model projects NAVN could trade at an average price of $58.28, with a potential range between $43.71 and $72.85. This represents a potential 123.4% return from today's price ...

Looking ahead to 2030, our model projects FLY could trade at an average price of $115.03, with a potential range between $86.27 and $143.78. This represents a potential 302.8% return from today's ...